Connect with us

Headlines

J&J Splits Into 2 Organizations

Its pharmaceutical and medical device business will stand alone, as will consumer products.

mm

Published

on

Johnson & Johnson (New Brunswick, N.J.) will separate its pharmaceutical and medical device business from its consumer products division, reports Quartz. The split is expected to be completed in two years.

While the consumer products business will be part of a newly named, publicly traded company, the pharma/medical device business will remain under the J&J banner. The prescription drug and medical device divisions are the brand owner’s fastest-growing and most profitable businesses. Consumer products, on the other hand is slower-growing and is also facing numerous lawsuits regarding its talc products.

SPONSORED VIDEO

SPONSORED BY VARILUX

The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines

Advertisement

Advertisement

Subscribe

INVISIONMAG.COM
BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Advertisement

Most Popular